Page last updated: 2024-12-06

ethylnorepinephrine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Ethylnorepinephrine is a synthetic, non-catecholic analog of norepinephrine. It is structurally similar to norepinephrine, but with an ethyl group replacing the hydroxyl group at the beta position. Its synthesis involves a multi-step process, starting with the condensation of phenylacetaldehyde with a suitable amine. Ethylnorepinephrine is a potent vasoconstrictor and is known to have effects on both the central and peripheral nervous systems. Research into ethylnorepinephrine is primarily focused on its potential therapeutic applications, particularly in the treatment of cardiovascular diseases, such as hypertension. The compound's vasoconstricting properties make it a potential candidate for the treatment of hypotension and shock. Additionally, ethylnorepinephrine has been studied for its potential to modulate neurotransmission and its possible applications in the treatment of neurological disorders. The compound's unique pharmacological profile, combined with its structural resemblance to norepinephrine, makes it a valuable subject for ongoing research in the field of neuropharmacology.'

ethylnorepinephrine: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID18538
CHEMBL ID31159
CHEBI ID134857
SCHEMBL ID249736
MeSH IDM0046099

Synonyms (42)

Synonym
DIVK1C_006886
SPECTRUM_001541
SPECTRUM5_001482
BSPBIO_003438
KBIO1_001830
KBIO2_007157
KBIO2_004589
KBIOSS_002021
KBIO3_002941
KBIOGR_001048
KBIO2_002021
SPECPLUS_000790
SPECTRUM2_001644
SPBIO_001767
SPECTRUM4_000584
SPECTRUM3_001899
NCGC00178063-01
CHEBI:134857
ethylnorepinephrine
CHEMBL31159
4-(2-amino-1-hydroxybutyl)benzene-1,2-diol
m6ay4vcz0a ,
536-24-3
alpha-(1-aminopropyl)-3,4-dihydroxybenzyl alcohol
unii-m6ay4vcz0a
SCHEMBL249736
.alpha.-(1-aminopropyl)-3,4-dihydroxybenzyl alcohol
ethylnorepinephrine [mi]
ethylnorepinephrine [who-dd]
(+/-)-ethylnorepinephrine
ethylnorepinephrine [vandf]
e.n.e
e.n.s.
4-(2-amino-1-hydroxybutyl)-1,2-benzenediol
LENNRXOJHWNHSD-UHFFFAOYSA-N
CS-4701
HY-B1105
AB00053708_02
SBI-0051921.P002
Q5404510
DTXSID10968369
etanor;butanephrine
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
catecholsAny compound containing an o-diphenol component.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID1136413Displacement of (-)-[3H]alprenolol from adrenergic receptor purified from frog erythrocytes relative to isoproterenol1978Journal of medicinal chemistry, Sep, Volume: 21, Issue:9
Structure-activity study of beta-adrenergic agents using the SIMCA method of pattern recognition.
AID1136412Displacement of (-)-[3H]alprenolol from adrenergic receptor purified from frog erythrocytes1978Journal of medicinal chemistry, Sep, Volume: 21, Issue:9
Structure-activity study of beta-adrenergic agents using the SIMCA method of pattern recognition.
AID215613Dissociation constant against a series of agonists of membranes of the turkey erythrocyte containing mainly Beta adrenergic receptor was determined1982Journal of medicinal chemistry, Dec, Volume: 25, Issue:12
Correlation between affinity toward adrenergic receptors and approximate electrostatic potentials of phenylethylamine derivatives. 1. Effects of the side chain.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (83.33)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.67

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.67 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.67)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (16.67%)4.05%
Observational0 (0.00%)0.25%
Other5 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]